三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
伏美替尼针对EGFR20外显子插入患者的疗效
伏美替尼针对EGFR20外显子插入患者的疗效
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:247KB
图片尺寸:1894*848
同报告图片
/
4
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
5aW955qE77yM5Lul5LiL5piv5oKo5Zu+54mH5Lit55qE5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IOe6v+ayu+eWl+S4u+imgee7iOeCuVBGU+e7k+aenCB8IOS8j+e+juabv+WwvOazqOWGjOS4tOW6iueglOeptiB8IOWlpeW4jOabv+WwvOWFqOeQg+eglOeptiB8IOWlpeW4jOabv+WwvOS4reWbveazqOWGjOS4tOW6iueglOeptiB8IOmYv+e+juabv+WwvOazqOWGjOS4tOW6iueglOeptiB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS18Cnwg5pWw5o2uICAgICAgICAgICAgICAgICAgfCAyMC44IHZzIDExLjHkuKrmnIggICAgfCAxOC45IHZzIDEwLjLkuKrmnIggfCAxNy44IHZzIDkuOOS4quaciCAgICAgICAgIHwgMTkuMyB2cyA5LjnkuKrmnIggICAgIHwKfCBIUiAgICAgICAgICAgICAgICAgICB8IDAuNDQgKDk1JUNJIDAuMzQtMC41OCkgfCAwLjQ2ICg5NSVDSSAwLjM3LTAuNTcpIHwgMC41NiAoOTUlQ0kgMC4zNy0wLjg1KSB8IDAuNDYzICg5NSVDSSAwLjM1OS0wLjU5NikgfAp8IHDlgLwgICAgICAgICAgICAgICAgICB8IDwgMC4wMDAxICAgICAgICAgICAgfCA8IDAuMDAxICAgICAgICAgIHwgPSAwLjAwNyAgICAgICAgICAgICAgICAgfCA8IDAuMDAwMSAgICAgICAgICAgIHwKCnwg5LqM57q/5rK755aX5Li76KaB57uI54K5T1JS57uT5p6cIHwg5LyP576O5pu/5bC85rOo5YaM5Li05bqK56CU56m2IHwg5aWl5biM5pu/5bC85YWo55CD56CU56m2IHwg5aWl5biM5pu/5bC85Lit5Zu95rOo5YaM5Li05bqK56CU56m2IHwg6Zi/576O5pu/5bC85rOo5YaM5Li05bqK56CU56m2IHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCBPUlIgICAgICAgICAgICAgICAgICB8IDc0JSAgICAgICAgICAgICAgICAgfCA3MSUgICAgICAgICAgICAgIHwgNjMlICAgICAgICAgICAgICAgICAgICAgfCA2OC45JSAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWbveWutuWMu+S/neWxgO+8jOWkquW5s+a0i+ivgeWIuOaVtOeQhg==
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
所属报告:
艾力斯-公司研究报告-肺癌领域深度布局产品矩阵逐步成型-250423(31页).pdf
打包全文图表
相关数据
伏美替尼Ib期FAVOUR研究安全性数据
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
收藏
行业数据
2025-07-14
原图定位
查看详情
伏美替尼一线治疗不良反应谱(非头对头)
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
收藏
行业数据
2025-07-14
原图定位
查看详情
外显子21(L858R)和外显子19缺失亚组PFS率对比
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
收藏
行业数据
2025-06-09
原图定位
查看详情
外显子21(L858R)和外显子19缺失亚组颅内PFS率对比
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
收藏
行业数据
2025-06-09
原图定位
查看详情
伏美替尼一线及二线治疗的有效性数据
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
收藏
行业数据
2025-04-25
原图定位
查看详情
伏美替尼与同类药品对比的有效性
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
收藏
行业数据
2025-04-25
原图定位
查看详情
伏美替尼常见不良反应类型及发生频率(发
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
收藏
行业数据
2025-04-25
原图定位
查看详情
伏美替尼针对脑转移患者的OS(A)和TTD(B)的KM曲线
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
收藏
行业数据
2025-04-25
原图定位
查看详情
伏美替尼一线治疗的整体中位PFS达到了20.8个月
fCDoja/niakgICAgICAgICAgICAgICB8IFBGU+S4reS9jeaVsO+8iDk1JUNJ77yJIHwgQ05TIFBGU+S4reS9jeaVsO+8iDk1JUNJ77yJIHwKfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tfAp8IEZpcm1vbmVydGluaWIgKDgwIG1nKSB8IDIwLjggKDE3LjgtMjMuNSkgfCAyMC44ICgxNS4yLTI1LjMpIHwKfCBHZWZpdGluaWIgKDI1MCBtZykgICB8IDExLjEgKDkuNy0xMi41KSAgfCA5LjggKDcuMi0xOC4wKSAgIHwKCui1hOaWmeadpea6kO+8mkFycmlWZW505a6Y572R77yMQVNDTyAyMDIy77yM5aSq5bmz5rSL6K+B5Yi45pW055CG
收藏
行业数据
2025-04-25
原图定位
查看详情
国内EGFR-TKI竞争格局:伏美替尼位列第一梯队
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
收藏
竞争格局
2025-03-14
原图定位
查看详情
三代EGFR-TKI二线适应症单药治疗:伏美替尼数据优异,脑转患者响应率及安全性方面尤具优势(非头
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
收藏
行业数据
2025-03-07
原图定位
查看详情
EGFRExon20ins新兴疗法:莫博赛替尼撤市,舒沃替尼、埃万妥获批,伏美替尼在研
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
收藏
行业数据
2025-03-07
原图定位
查看详情
一线EGFRExon20ins:伏美替尼初步疗效数据优异(非头对头对比)
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
收藏
行业数据
2025-03-07
原图定位
查看详情
国内EGFR-TKI竞争格局:伏美替尼位列第一梯队
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
收藏
竞争格局
2025-03-07
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
对于确诊 EGFR-TKI 耐药且 20 外显子 T790M 突变的患者,第三代 EGFR-TKI 为推荐的二线疗法。伏美替尼一线治疗EGFR 20号外显子插入突变非小细胞肺癌的关键 III期注册临床 FUVENT研究(NCT05607550 / CTR20231409)正在进行中,有望 2025 年在美国提交上市申请。
行业数据
原图定位
当前图表所属:
艾力斯-公司研究报告-肺癌领域深度布局产品矩阵逐步成型-250423(31页).pdf
与同类产品安全性数据的比较(非头对头)
伏美替尼常见不良反应类型及发生频率(发
伏美替尼与同类药品对比的有效性
伏美替尼一线及二线治疗的有效性数据
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》